A novel class of small functional peptides that bind and inhibit human α-thrombin isolated by mRNA display

Chemistry and Biology

Volumn 10, Issue 1, 2003, Pages 69-79

  Raffler, Nikolai A ^a   Schneider Mergener, Jens ^b,c   Famulok, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Jerini AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037253816     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00309-5     Document Type: Article

References (58)

1. Smith G.P. Filamentous fusion phage. novel expression vectors that display cloned antigens on the virion surface Science. 228:1985;1315-1317.
2. Smith G.P., Petrenko V.A. Phage display. Chem. Rev. 97:1997;391-410.
3. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. USA. 91:1994;9022-9026.
4. Hanes J., Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. USA. 94:1997;4937-4942.
5. Hanes J., Jermutus L., Plückthun A. Selecting and evolving functional proteins in vitro by ribosome display. Methods Enzymol. 328:2000;404-430.
6. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA. 94:1997;12297-12302.
7. Nemoto N., Miyamoto-Sato E., Husimi Y., Yanagawa H. In vitro virus. bonding of mRNA bearing puromycin at the 3′-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro FEBS Lett. 414:1997;405-408.
8. Liu R., Barrick J.E., Szostak J.W., Roberts R.W. Optimized synthesis of RNA-protein fusions for in vitro protein selection. Methods Enzymol. 318:2000;268-293.
9. Cho G., Keefe A.D., Liu R., Wilson D.S., Szostak J.W. Constructing high complexity synthetic libraries of long ORFs using in vitro selection. J. Mol. Biol. 297:2000;309-319.
10. Barrick J.E., Takahashi T.T., Balakin A., Roberts R.W. Selection of RNA-binding peptides using mRNA-peptide fusions. Methods. 23:2001;287-293.
11. Keefe A.D., Szostak J.W. Functional proteins from a random-sequence library. Nature. 410:2001;715-718.
12. Wilson D.S., Keefe A.D., Szostak J.W. The use of mRNA display to select high-affinity protein-binding peptides. Proc. Natl. Acad. Sci. USA. 98:2001;3750-3755.
13. Stubbs M.T., Bode W. The clot thickens. clues provided by thrombin structure Trends Biochem. Sci. 20:1995;23-28.
14. Mann K.G., Jenny R.J., Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu. Rev. Biochem. 57:1988;915-956.
15. Kane W.H., Davie E.W. Blood coagulation factors V and VIII. structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders Blood. 71:1988;539-555.
16. Gailani D., Broze G.J. Jr. Factor XI activation in a revised model of blood coagulation. Science. 253:1991;909-912.
17. Bode W., Mayr I., Baumann U., Huber R., Stone S.R., Hofsteenge J. The refined 1.9 Å crystal structure of human alpha-thrombin. interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment EMBO J. 8:1989;3467-3475.
18. Stone S.R., Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 25:1986;4622-4628.
19. Rydel T.J., Ravichandran K.G., Tulinsky A., Bode W., Huber R., Roitsch C., Fenton J.W. 2nd. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science. 249:1990;277-280.
20. Grütter M.G., Priestle J.P., Rahuel J., Grossenbacher H., Bode W., Hofsteenge J., Stone S.R. Crystal structure of the thrombin-hirudin complex. a novel mode of serine protease inhibition EMBO J. 9:1990;2361-2365.
21. Skrzypczak-Jankun E., Carperos V.E., Ravichandran K.G., Tulinsky A., Westbrook M., Maraganore J.M. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J. Mol. Biol. 221:1991;1379-1393.
22. Richardson J.L., Kroger B., Hoeffken W., Sadler J.E., Pereira P., Huber R., Bode W., Fuentes-Prior P. Crystal structure of the human alpha-thrombin-haemadin complex. an exosite II-binding inhibitor EMBO J. 19:2000;5650-5660.
23. Strube K.H., Kroger B., Bialojan S., Otte M., Dodt J. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. J. Biol. Chem. 268:1993;8590-8595.
24. Sheehan J.P., Wu Q., Tollefsen D.M., Sadler J.E. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. J. Biol. Chem. 268:1993;3639-3645.
25. Sheehan J.P., Tollefsen D.M., Sadler J.E. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans. J. Biol. Chem. 269:1994;32747-32751.
26. Le Bonniec B.F., Guinto E.R., Esmon C.T. Interaction of thrombin des-ETW with antithrombin III, the Kunitz inhibitors, thrombomodulin and protein C. Structural link between the autolysis loop and the Tyr-Pro-Pro-Trp insertion of thrombin. J. Biol. Chem. 267:1992;19341-19348.
27. Lombardi A., De Simone G., Galdiero S., Staiano N., Nastri F., Pavone V. From natural to synthetic multisite thrombin inhibitors. Biopolymers. 51:1999;19-39.
28. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:1989;4743-4746.
29. Esmon C.T. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J. 9:1995;946-955.
30. Li C.Q., Vindigni A., Sadler J.E., Wardell M.R. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. J. Biol. Chem. 276:2001;6161-6168.
31. Keefe A.D. Protein selection using mRNA display. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 2001;24 Wiley, New York. 5.unit.
32. Baggio R., Burgstaller P., Hale S.P., Putney A.R., Lane M., Lipovsek D., Wright M.C., Roberts R.W., Liu R., Szostak J.W.et al. Identification of epitope-like consensus motifs using mRNA display. J. Mol. Recognit. 15:2002;126-134.
33. Cujec T.P., Medeiros P.F., Hammond P., Rise C., Kreider B.L. Selection of v-abl tyrosine kinase substrate sequences from randomized peptide and cellular proteomic libraries using mRNA display. Chem. Biol. 9:2002;253-264.
34. Barrick J.E., Takahashi T.T., Ren J., Xia T., Roberts R.W. Large libraries reveal diverse solutions to an RNA recognition problem. Proc. Natl. Acad. Sci. USA. 98:2001;12374-12378.
35. Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature. 355:1992;564-566.
36. Kubik M.F., Stephens A.W., Schneider D., Marlar R.A., Tasset D. High-affinity RNA ligands to human alpha-thrombin. Nucleic Acids Res. 22:1994;2619-2626.
37. Fredenburgh J.C., Stafford A.R., Weitz J.I. Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J. Biol. Chem. 272:1997;25493-25499.
38. Fredenburgh J.C., Stafford A.R., Weitz J.I. Conformational changes in thrombin when complexed by serpins. J. Biol. Chem. 276:2001;44828-44834.
39. Rydel T.J., Tulinsky A., Bode W., Huber R. Refined structure of the hirudin-thrombin complex. J. Mol. Biol. 221:1991;583-601.
40. Padmanabhan K., Padmanabhan K.P., Ferrara J.D., Sadler J.E., Tulinsky A. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J. Biol. Chem. 268:1993;17651-17654.
41. Padmanabhan K., Tulinsky A. An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr. D. 52:1996;272-282.
42. Fuentes-Prior P., Iwanaga Y., Huber R., Pagila R., Rumennik G., Seto M., Morser J., Light D.R., Bode W. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature. 404:2000;518-525.
43. Reineke U., Volkmer-Engert R., Schneider-Mergener J. Applications of peptide arrays prepared by the SPOT-technology. Curr. Opin. Biotechnol. 12:2001;59-64.
44. Toepert F., Pires J.R., Landgraf C., Oschkinat H., Schneider-Mergener J. Synthesis of an array comprising 837 variants of the hYAP WW protein domain. Angew Chem. Int. Ed. Engl. 40:2001;897-900.
45. Kramer A., Reineke U., Dong L., Hoffmann B., Hoffmüller U., Winkler D., Volkmer-Engert R., Schneider-Mergener J. Spot synthesis. observations and optimizations J. Pept. Res. 54:1999;319-327.
46. Dennis M.S., Eigenbrot C., Skelton N.J., Ultsch M.H., Santell L., Dwyer M.A., O'Connell M.P., Lazarus R.A. Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature. 404:2000;465-470.
47. Suzuki K., Nishioka J., Hayashi T. Localization of thrombomodulin-binding site within human thrombin. J. Biol. Chem. 265:1990;13263-13267.
48. Wolf E., Kim P.S. Combinatorial codons. a computer program to approximate amino acid probabilities with biased nucleotide usage Protein Sci. 8:1999;680-688.
49. Pollard J., Bell S., Ellington A.D. Design, synthesis and amplification of DNA pools for in vitro selection. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Nucleic Acid Chemistry. 2000;9 Wiley, New York. 2.1.unit.
50. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
51. Tsiang M., Jain A.K., Dunn K.E., Rojas M.E., Leung L.L., Gibbs C.S. Functional mapping of the surface residues of human thrombin. J. Biol. Chem. 270:1995;16854-16863.
52. Rose T., Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J. Biol. Chem. 277:2002;18875-18880.
53. Van Deerlin V.M., Tollefsen D.M. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. J. Biol. Chem. 266:1991;20223-20231.
54. Hall S.W., Nagashima M., Zhao L., Morser J., Leung L.L. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J. Biol. Chem. 274:1999;25510-25516.
55. Pineda A.O., Cantwell A.M., Bush L.A., Rose T., Di Cera E. The thrombin epitope recognizing thrombomodulin is a highly cooperative hot spot in exosite I. J. Biol. Chem. 277:2002;32015-32019.
56. Wu Q., Tsiang M., Sadler J.E. Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite. J. Biol. Chem. 267:1992;24408-24412.
57. De Cristofaro R., De Candia E., Rutella S., Weitz J.I. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. J. Biol. Chem. 275:2000;3887-3895.
58. De Marco L., Mazzucato M., Masotti A., Ruggeri Z.M. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J. Biol. Chem. 269:1994;6478-6484.